PATENT CLAIM ANALYSIS

Application Number: 16085447
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-09
Patent Classification: ["514", "228800"]

Abstract:
Compounds of the formula (I) wherein the substituents are as defined in claim  1 , useful as a pesticides, especially as fungicides.

Claim (Index 1):
A compound of formula (I): wherein n represents 0 or 1; A 1  represents N or CR 1 , wherein R 1  is hydrogen, halogen, methyl, ethyl, difluoromethyl, or difluoromethoxy; A 2  represents N or CR 2 , wherein R 2  is hydrogen, halogen, methyl, ethyl, difluoromethyl, or difluoromethoxy; R 3  and R 4  independently represent hydrogen or halogen; R 5  and R 6  independently represent hydrogen or methyl; R 7  is hydrogen, C 1-4 alkyl, C 1-4 alkylcarbonyl, C 1-4 alkylaminocarbonylC 1-4 alkyl, di-C 1-4  alkylaminocarbonylC 1-4 alkyl, C 1-4 alkylaminocarbonyl, phenylcarbonyl, or C 3-6 cycloalkyl; Z represents \u2014NR 8 R 9 , wherein R 8  represents hydrogen or C 1-4 alkyl; R 9  represents hydrogen, C 1-4 alkyl, C 3-6 alkenyl, C 3-6 alkynyl, C 1-4 haloalkyl, cyanoC 1-6 alkyl, hydroxyC 1-6 alkyl, C 1-4 alkoxyC 1-6 alkyl, C 1-2 fluoroalkoxyC 1-6 alkyl, C 1-4 alkylcarbonyl, C 1-4 alkylcarbonylC 1-6 alkyl, C 1-4 haloalkylcarbonyl, C 1-4 haloalkylaminocarbonyl, C 1-4 alkoxycarbonyl, C 1-4 alkoxycarbonylC 1-6 alkyl, C 1-4 alkylaminocarbonyl, di-C 1-4 alkylaminocarbonyl, C 1-4 alkylaminothiocarbonyl, di-C 1-4 alkylaminothiocarbonyl, C 3-8 cycloalkyl, C 3-8 cycloalkylC 1-3 alkyl, phenyl, phenylC 1-3 alkyl, phenylcarbonyl, heteroaryl, heteroarylC 1-3 alkyl, heteroarylcarbonyl, wherein the heteroaryl moiety is a 5- or 6-membered aromatic ring which comprises 1, 2, 3 or 4 heteroatoms individually selected from N, O and S, heterocyclyl, heterocyclylC 1-3 alkyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1, 2 or 3 heteroatoms individually selected from N, O and S, or heterobicyclyl, wherein the heterobicyclyl moiety is a 7- to 11-membered aromatic, saturated or partially saturated fused ring system which comprises 1, 2 or 3 heteroatoms selected from N, O and S, and wherein any of said cycloalkyl, phenyl, heteroaryl, heterocyclyl or heterobicyclyl moieties is optionally substituted by 1, 2, 3 or 4 substituents, which may be the same or different, selected from R 10 ; R 10  represents cyano, amino, halogen, hydroxy, C 1-4 alkyl, methoxy, ethoxy, allyl, propargyl, difluoromethyl, trifluoromethyl, or difluoromethoxy; or R 8  and R 9 , together with the nitrogen atom to which they are attached, form a 5- or 6-membered non-aromatic heterocyclic ring which optionally additionally comprises 1, 2 or 3 heteroatoms individually selected from N, O and S, wherein the heterocyclic ring is optionally substituted by 1, 2, 3, or 4 substituents, which may be the same or different, selected from R 11 ; or R 8  and R 9 , together with the nitrogen atom to which they are attached, form a 7- to 11-membered heteroaromatic or non-aromatic heterocyclic fused ring system which optionally additionally comprises 1, 2 or 3 heteroatoms individually selected from N, O and S, wherein said heteroaromatic or heterocyclic fused ring system is optionally substituted by 1, 2, 3, or 4 substituents, which may be the same or different, selected from R 11 ; and R 11  represents cyano, amino, halogen, hydroxy, C 1-4 alkyl, C 1-2 fluoroalkyl, C 1-4 alkoxy, C 1-2 alkoxyC 1-4 alkyl, allyl, or propargyl and R 11  may also represent oxo on a non-aromatic heterocyclic moiety; or a salt or an N-oxide thereof; with the proviso that the compound of formula (I) is not: N\u2032-benzoyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzohydrazide; 1-(2,2,2-trifluoroethyl)-3-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzoyl]amino]urea; N-morpholin-4-yl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide; N\u2032-(3-methylphenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzohydrazide; 4-methyl-N\u2032-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzoyl]-1,3-thiazole-5-carbohydrazide; 3-methyl-N\u2032-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzoyl]thiophene-2-carbohydrazide; 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzohydrazide; or 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzohydrazide hydrochloride salt.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.18182
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16091859', '16339995', '14131558', '15765089', '14348946']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8053371917594455
- 35 USC 102 Novelty (BERT): 0.54555736671402
- Combined Prediction Score: 0.779359209254903
- Mean Citation Score: 330.69882
- Max Citation Score: 395.95154
- Similarity Product: 343.0230565300846

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test